Find the Perfect Plan for Your Investment Journey
A
Latest price
52 Week Range
CA$0.17 - CA$4.71
Next Earnings Date
May 13 2025
Next Earnings Date
May 13 2025
Latest price
Market Cap | CA$26.86M |
EV | CA$849.48M |
Shares Outstanding | 116.77M |
Beta | 1.86 |
Analyst Rating | HOLD |
Analyst Target Price | CA$1.10 |
P/E 2025E | - |
P/Revenue 2025E | 0.04x |
Revenue | 9.00% |
EPS | -130.30% |
Operating Cash Flow | - |
Free Cash Flow | 60.20% |
Revenue | 0.50% |
EPS | 39.40% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 41.97% |
Net Profit Margin 2025E | -30.62% |
ROE 2025E | -30.10% |
ROCE 2024 | -74.75% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
Ayr Wellness Inc.
AYR.A
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Cohen, Steven
Employees
2,440
Website
www.ayrwellness.comIPO Date
2019-08-20
Headquarters
2601 South Bayshore Drive, Suite 900, Miami, Florida, 33133, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved